Clinical Trial Update: Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

This Phase 2 trial compared efficacy and safety of T4090 ophthalmic solution to Rhopressa in Open-angle glaucoma or ocular hypertension; results have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Rhopressa ophthalmic solution (netarsudil)
• T4090 ophthalmic solution

Snippet

Sponsor: Laboratoires Thea | Conditions: Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2026-01-02